As demand for effective diabetes and weight-management treatments continues to grow, this innovation could help improve treatment adherence, expand patient access, and strengthen Indias fight against chronic metabolic diseases.
Individuals who may warrant closer monitoring include: Those with a personal or family history of depression , anxiety, or other mood disorders People who have previously experienced mood changes on other weight-loss medications or GLP-1-based therapies Individuals with eating disorders or a complex relationship with food , for whom appetite suppression may have psychological implications (see NICE guideline NG69: Eating disorders: recognition and treatment) [10] Those experiencing significant life stressors alongside starting a new treatment People with poorly controlled type 2 diabetes , where fluctuating blood glucose levels both hypoglycaemia and hyperglycaemia can independently affect mood, concentration, and emotional wellbeing It is also worth acknowledging that obesity itself is associated with higher rates of depression and anxiety, and that the psychological experience of rapid body weight change whether positive or negative can be emotionally complex
therefore, it is particularly popular among bodybuilders
Depending on the research question, glutathione profiling may be combined with lipid-peroxidation products, GSH conjugates, or other pathway-specific metabolites
They also target signals between the gut and the brain that control appetite and feelings of fullness, and by slowing how fast the stomach empties
They may recommend: eating smaller, bland meals while you recover drinking plenty of water to stay hydrated
